ClinicalTrials.govpublic full text
3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
neuroblastoma, solid tumor, neuroblastoma-specific immunotherapy targeting gd2, car t cells, gene therapy, relapsed, refractory, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1045689
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.